FDA: Brintellix Changing Name to Avoid Confusion With Brilinta

Share this content:
FDA: Brintellix Changing Name to Avoid Confusion With Brilinta
FDA: Brintellix Changing Name to Avoid Confusion With Brilinta

TUESDAY, May 3, 2016 (HealthDay News) -- Following a July 2015 Drug Safety Communication that warned about name confusion between Brintellix and Brilinta resulting in prescribing errors, the antidepressant Brintellix (vortioxetine) is changing its name to Trintellix, according to the U.S. Food and Drug Administration.

The drug with its new brand name is expected to be available in June 2016. There will be no other changes made to the label or packaging, and the medicine is unchanged. During the transition period, health care professionals and patients may continue to see bottles labeled with the old brand name due to the lag time associated with manufacturing bottles with the new brand name.

In order to reduce confusion between Brintellix and the antiplatelet medication Brilinta (ticagrelor), prescribers should include the generic name of the medication they are ordering, as well as the brand name and indications for use; patients should ensure that they have received the correct medication. Since the July 2015 Drug Safety Communication, five additional cases describing brand name confusion have been reported, bringing the total to 55 cases.

"We urge health care professionals and patients to report name confusion, medication errors, and any side effects involving Brintellix/Trintellix or Brilinta to the FDA MedWatch program," the agency said in a drug safety communication.

More Information

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »